Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Fingerprint
Dive into the research topics where Boris A. Reva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comprehensive proteogenomic characterization of rare kidney tumors
Chinnaiyan, A. M., Cieslik, M., Dhanasekaran, S. M., Zhang, H., Nesvizhskii, A. I. & Clinical Proteomic Tumor Analysis Consortium, 21 May 2024, In: Cell Reports Medicine. 5, 5, 101547.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Erratum: Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer (Cell (2023) 186(16) (3476–3498.e35), (S0092867423007377), (10.1016/j.cell.2023.07.004))
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A., Savage, S. R., Berry, A. B., Reva, B., Ozbek, U., Krek, A., Ma, W., da Veiga Leprevost, F., Ji, J., Yoo, S., Lin, C., Voytovich, U. J. & Huang, Y. & 27 others, , 15 Feb 2024, In: Cell. 187, 4, p. 1016 1 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue
Pandya, D., Tomita, S., Rhenals, M. P., Swierczek, S., Reid, K., Camacho-Vanegas, O., Camacho, C., Engelman, K., Polukort, S., RoseFigura, J., Chuang, L., Andikyan, V., Cohen, S., Fiedler, P., Sieber, S., Shih, I. M., Billaud, J. N., Sebra, R., Reva, B. & Dottino, P. & 1 others, , Jun 2024, In: Gynecologic Oncology. 185, p. 194-201 8 p.Research output: Contribution to journal › Article › peer-review
-
Pan-cancer proteogenomics characterization of tumor immunity
Clinical Proteomic Tumor Analysis Consortium, 29 Feb 2024, In: Cell. 187, 5, p. 1255-1277.e27Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Clinical Proteomic Tumor Analysis Consortium, 19 Sep 2023, In: Cell Reports Medicine. 4, 9, 101173.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Reveals New Findings on Cancer (Pan-cancer Proteogenomics Characterization of Tumor Immunity)
Reva, B. A., Sebra, R., Wang, P., Song, X., Ma’ayan, A., Petralia, F. & Chowdhury, S.
4/06/24
1 item of Media coverage
Press/Media
-
Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy
Reva, B. A., Özbek, U., Wang, P., Song, X. & Petralia, F.
19/11/23
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Ovarian Cancer - New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy
Reva, B. A., Özbek, U., Wang, P., Song, X., Petralia, F. & Chowdhury, S.
3/08/23 → 4/08/23
2 items of Media coverage
Press/Media
-
Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy
Reva, B. A., Özbek, U., Wang, P., Song, X., Petralia, F. & Chowdhury, S.
3/08/23
75 items of Media coverage
Press/Media
-
Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy.
Reva, B. A., Özbek, U., Wang, P., Song, X., Petralia, F. & Chowdhury, S.
3/08/23
1 item of Media coverage
Press/Media